Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Thomas, J., Paulet, M
This monthly supply model eliminates the risk of expired doses sitting in your refrigerator unused
Triple receptor agonist: GLP-1 + GIP + Glucagon Latest Phase 3 Highlights (23 July 2026) TRIUMPH-2 22.6% mean weight loss in adults with obesity and cardiovascular disease TRIUMPH-3 20.8% mean weight loss in adults with obesity and type 2 diabetes ~1.6% HbA1c reduction Next milestone Eli Lilly plans to submit its first FDA application for Retatrutide in Q1 2027
This makes it a great addition to post-workout nutrition
)
US$ 28.59
US$ 28.71
US$ 20.73
US$ 22.46
US$ 25.70
US$ 22.78
US$ 23.39
